Skiba, Meredith A.
Sterling, Sarah M.
Rawson, Shaun https://orcid.org/0000-0002-2973-2630
Zhang, Shuhao https://orcid.org/0000-0002-0301-5983
Xu, Huixin
Jiang, Haoran https://orcid.org/0000-0001-5916-3072
Nemeth, Genevieve R.
Gilman, Morgan S. A.
Hurley, Joseph D. https://orcid.org/0000-0002-3903-318X
Shen, Pengxiang https://orcid.org/0000-0002-6941-4741
Staus, Dean P.
Kim, Jihee
McMahon, Conor
Lehtinen, Maria K.
Rockman, Howard A. https://orcid.org/0000-0003-2921-1584
Barth, Patrick https://orcid.org/0000-0002-0744-6844
Wingler, Laura M. https://orcid.org/0000-0002-3688-5088
Kruse, Andrew C. https://orcid.org/0000-0002-1467-1222
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R21HD101596)
U.S. Department of Health & Human Services | National Institutes of Health (R01CA260415)
U.S. Department of Health & Human Services | National Institutes of Health (K99HD110612)
Helen Hay Whitney Foundation
Howard Hughes Medical Institute
New York Stem Cell Foundation
Pew Charitable Trusts
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A_182263)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_208179)
Ludwig Institute for Cancer Research
Article History
Received: 17 July 2023
Accepted: 12 April 2024
First Online: 14 May 2024
Competing interests
: A.C.K., C.M., L.M.W., D.P.S. and M.A.S. are co-inventors on a patent application for AT1R blocking nanobodies. A.C.K. is a cofounder and consultant for biotechnology companies Tectonic Therapeutic and Seismic Therapeutic, and also for the Institute for Protein Innovation, a nonprofit research institute. L.M.W. is a scientific advisor for Septerna. D.P.S. is a Septerna employee. C.M. is a Sanofi employee. P.B. holds patents and provisional patent applications in the field of engineered T-cell therapies and protein design. The other authors declare no competing interests.